343 related articles for article (PubMed ID: 26269004)
1. Unexpectedly High Prevalence of Acquired von Willebrand Syndrome in Patients with Severe Aortic Stenosis as Evaluated with a Novel Large Multimer Index.
Tamura T; Horiuchi H; Imai M; Tada T; Shiomi H; Kuroda M; Nishimura S; Takahashi Y; Yoshikawa Y; Tsujimura A; Amano M; Hayama Y; Imamura S; Onishi N; Tamaki Y; Enomoto S; Miyake M; Kondo H; Kaitani K; Izumi C; Kimura T; Nakagawa Y
J Atheroscler Thromb; 2015; 22(11):1115-23. PubMed ID: 26269004
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter aortic valve implantation leads to a restoration of von Willebrand factor (VWF) abnormalities in patients with severe aortic stenosis - Incidence and relevance of clinical and subclinical VWF dysfunction in patients undergoing transfemoral TAVI.
Sedaghat A; Kulka H; Sinning JM; Falkenberg N; Driesen J; Preisler B; Hammerstingl C; Nickenig G; Pötzsch B; Oldenburg J; Hertfelder HJ; Werner N
Thromb Res; 2017 Mar; 151():23-28. PubMed ID: 28088607
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding.
Casonato A; Sponga S; Pontara E; Cattini MG; Basso C; Thiene G; Cella G; Daidone V; Gerosa G; Pagnan A
Thromb Haemost; 2011 Jul; 106(1):58-66. PubMed ID: 21544311
[TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand Syndrome Hiding Inherited von Willebrand Disease Can Explain Severe Bleeding in Patients With Aortic Stenosis.
Casonato A; Galletta E; Cella G; Barbon G; Daidone V
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2187-2194. PubMed ID: 32640909
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses.
Blackshear JL; McRee CW; Safford RE; Pollak PM; Stark ME; Thomas CS; Rivera CE; Wysokinska EM; Chen D
JAMA Cardiol; 2016 May; 1(2):198-204. PubMed ID: 27437891
[TBL] [Abstract][Full Text] [Related]
6. Severe Aortic Valve Stenosis.
Frank RD; Lanzmich R; Haager PK; Budde U
Clin Appl Thromb Hemost; 2017 Apr; 23(3):229-234. PubMed ID: 27481874
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Heyde's syndrome by abnormal closure times despite normal von Willebrand's activity.
D'Souza PM; Blostein MD
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):622-3. PubMed ID: 21760480
[TBL] [Abstract][Full Text] [Related]
8. Association between the severity of acquired von Willebrand syndrome and gastrointestinal bleeding after continuous-flow left ventricular assist device implantation.
Sakatsume K; Saito K; Akiyama M; Sasaki K; Kawatsu S; Takahashi G; Adachi O; Kawamoto S; Horiuchi H; Saiki Y
Eur J Cardiothorac Surg; 2018 Nov; 54(5):841-846. PubMed ID: 29741685
[TBL] [Abstract][Full Text] [Related]
9. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
[TBL] [Abstract][Full Text] [Related]
10. Acquired von Willebrand syndrome in aortic stenosis.
Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
[TBL] [Abstract][Full Text] [Related]
11. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation.
Tamura T; Horiuchi H; Obayashi Y; Fuki M; Imanaka M; Kuroda M; Nishimura S; Amano M; Sakamoto J; Tamaki Y; Enomoto S; Miyake M; Kondo H; Izumi C; Nakagawa Y
Cardiovasc Interv Ther; 2019 Oct; 34(4):358-363. PubMed ID: 30656612
[TBL] [Abstract][Full Text] [Related]
13. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
[TBL] [Abstract][Full Text] [Related]
14. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
[TBL] [Abstract][Full Text] [Related]
15. Jejunal Angiodysplasia in an Elderly Patient with Aortic Stenosis: Significance of Von Willebrand Factor as an Etiologic Factor.
Kubo T; Yoshii S; Yamano HO; Saito M; Sakata K; Sugita S; Hasegawa T; Horiuchi H; Nakase H
Intern Med; 2023 Jul; 62(14):2059-2062. PubMed ID: 36418102
[TBL] [Abstract][Full Text] [Related]
16. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement.
Bolliger D; Dell-Kuster S; Seeberger MD; Tanaka KA; Gregor M; Zenklusen U; Tsakiris DA; Filipovic M
Br J Anaesth; 2012 May; 108(5):754-62. PubMed ID: 22311365
[TBL] [Abstract][Full Text] [Related]
17. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
Rauch A; Caron C; Vincent F; Jeanpierre E; Ternisien C; Boisseau P; Zawadzki C; Fressinaud E; Borel-Derlon A; Hermoire S; Paris C; Lavenu-Bombled C; Veyradier A; Ung A; Vincentelli A; van Belle E; Lenting PJ; Goudemand J; Susen S
Thromb Haemost; 2016 May; 115(5):950-9. PubMed ID: 26791163
[TBL] [Abstract][Full Text] [Related]
18. Laboratory Testing for Von Willebrand Factor Multimers.
Oliver S; Lau KKE; Chapman K; Favaloro EJ
Methods Mol Biol; 2017; 1646():495-511. PubMed ID: 28804850
[TBL] [Abstract][Full Text] [Related]
19. Acquired von Willebrand Syndrome due to Aortic Valve Stenosis in a Case with Antiphospholipid Antibody.
Tanaka H; Nagai Y; Kuwabara C; Shimizu R; Umeki A; Yamamoto T
Intern Med; 2018 Jun; 57(11):1641-1644. PubMed ID: 29321442
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor Ristocetin co-factor activity to von Willebrand factor antigen level ratio for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis.
Okubo N; Sugawara S; Fujiwara T; Sakatsume K; Doman T; Yamashita M; Goto K; Tateishi M; Suzuki M; Shirakawa R; Eura Y; Kokame K; Hayakawa M; Matsumoto M; Kawate Y; Miura M; Takiguchi H; Soga Y; Shirai S; Ando K; Arai Y; Nakayoshi T; Fukumoto Y; Takahama H; Yasuda S; Tamura T; Watanabe S; Kimura T; Yaoita N; Shimokawa H; Saiki Y; Kaikita K; Tsujita K; Yoshii S; Nakase H; Fujimaki SI; Horiuchi H
Res Pract Thromb Haemost; 2024 Jan; 8(1):102284. PubMed ID: 38268521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]